These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

575 related items for PubMed ID: 6680095

  • 41. Development of a purified cholera toxoid. III. Refinements in purification of toxin and methods for the determination of residual somatic antigen.
    Rappaport RS, Pierzchala WA, Bonde G, McCann T, Rubin BA.
    Infect Immun; 1976 Sep; 14(3):687-93. PubMed ID: 823117
    [Abstract] [Full Text] [Related]

  • 42. Antigenic specificity of neutralizing antibody to cholera toxin.
    Peterson JW, Hejtmancik KE, Markel DE, Craig JP, Kurosky A.
    Infect Immun; 1979 Jun; 24(3):774-9. PubMed ID: 89089
    [Abstract] [Full Text] [Related]

  • 43. Studies on cholera toxin and antitoxin.
    Ungar J, Stanić M, Chariatte N, Varallyay SJ.
    J Gen Microbiol; 1970 Nov; 64(1):1-10. PubMed ID: 5516606
    [No Abstract] [Full Text] [Related]

  • 44. Priming and suppression of the intestinal immune response to cholera toxoid/toxin by parenteral toxoid in rats.
    Pierce NF, Koster FT.
    J Immunol; 1980 Jan; 124(1):307-11. PubMed ID: 6965294
    [Abstract] [Full Text] [Related]

  • 45. A toxoid prepared from cholera toxin by iodination.
    Heneine IF, Lahmann WM, Rocha OA.
    Braz J Med Biol Res; 1992 Jan; 25(9):913-7. PubMed ID: 1342838
    [Abstract] [Full Text] [Related]

  • 46. Intranasal immunization with recombinant toxin-coregulated pilus and cholera toxin B subunit protects rabbits against Vibrio cholerae O1 challenge.
    Kundu J, Mazumder R, Srivastava R, Srivastava BS.
    FEMS Immunol Med Microbiol; 2009 Jul; 56(2):179-84. PubMed ID: 19453752
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. [Evaluation of the ELISA method for cholera toxin determination in Vibrio cholerae cultures].
    González-Bonilla C, Gutiérrez-Cogco L, Moguel-Pech L, Villanueva-Zamudio A.
    Rev Latinoam Microbiol; 1994 Jul; 36(4):273-6. PubMed ID: 7701137
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Immunity to experimental cholera. II. Secretory and humoral antitoxin response to local and systemic toxoid administration.
    Pierce NF, Reynolds HY.
    J Infect Dis; 1975 Apr; 131(4):383-9. PubMed ID: 1117195
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. The detection of Clostridium perfringens epsilon antitoxin in rabbit serum by monoclonal antibody based competition ELISA.
    Sojka MG, White VJ, Thorns CJ, Roeder PL.
    J Biol Stand; 1989 Apr; 17(2):117-24. PubMed ID: 2715150
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 29.